TY - JOUR
T1 - Flexible and stretchable high performance enzymatic biofuel cells implantable in tube-type artificial blood vessel kit
AU - Lee, Joonyoung
AU - Ji, Jungyeon
AU - Han, Sunmin
AU - Kwon, Yongchai
N1 - Publisher Copyright:
© 2024 Elsevier B.V.
PY - 2024/6/30
Y1 - 2024/6/30
N2 - Enzymatic biofuel cells (EBFCs) are emerged as promising power sources for implantable devices, offering excellent form factor and performance. For these applications, EBFCs require customer tailored structure and more than 10 μW power. In this study, flexible and stretchable EBFCs are suggested, assessing their performance using tube-type artificial blood vessel (TABV) cell kit with sheep blood fuel. To fabricate the EBFCs, buckypaper (BP) is molded to polydimethylsiloxane (PDMS) to fabricate BP@PDMS electrode that shows excellent strain rate (95 %) and durability (1500 cycles) in tensile and fatigue tests. Additionally, electrochemical evaluations are implemented to measure the performance of anode and cathode fabricated with BP@PDMS. In anode including 1,10-phenanthroline-5,6-dione and glucose dehydrogenase, maximum reactivity of glucose oxidation is 1.05 mA/cm2, while in cathode including bilirubin oxidase, that of oxygen reduction is 0.61 mA/cm2. Regarding flexibility, anode and cathode are little affected by current density irrespective of bending angle, proving that the fabricated anode and cathode have good flexibility. To emulate the behavior of EBFCs in actual blood vessel, EBFCs are implanted in TABV cell kit, fueling sheep blood. Observed open circuit voltage of 0.59 V and maximum power of 26 μW reveals that fabricated EBFCs have superior potential to be considered as power sources for implantable devices.
AB - Enzymatic biofuel cells (EBFCs) are emerged as promising power sources for implantable devices, offering excellent form factor and performance. For these applications, EBFCs require customer tailored structure and more than 10 μW power. In this study, flexible and stretchable EBFCs are suggested, assessing their performance using tube-type artificial blood vessel (TABV) cell kit with sheep blood fuel. To fabricate the EBFCs, buckypaper (BP) is molded to polydimethylsiloxane (PDMS) to fabricate BP@PDMS electrode that shows excellent strain rate (95 %) and durability (1500 cycles) in tensile and fatigue tests. Additionally, electrochemical evaluations are implemented to measure the performance of anode and cathode fabricated with BP@PDMS. In anode including 1,10-phenanthroline-5,6-dione and glucose dehydrogenase, maximum reactivity of glucose oxidation is 1.05 mA/cm2, while in cathode including bilirubin oxidase, that of oxygen reduction is 0.61 mA/cm2. Regarding flexibility, anode and cathode are little affected by current density irrespective of bending angle, proving that the fabricated anode and cathode have good flexibility. To emulate the behavior of EBFCs in actual blood vessel, EBFCs are implanted in TABV cell kit, fueling sheep blood. Observed open circuit voltage of 0.59 V and maximum power of 26 μW reveals that fabricated EBFCs have superior potential to be considered as power sources for implantable devices.
KW - Buckypaper
KW - Enzymatic biofuel cells
KW - Polydimethylsiloxane
KW - Sheep blood fuel
KW - Tube-type artificial blood vessel
UR - https://www.scopus.com/pages/publications/85190842594
U2 - 10.1016/j.jpowsour.2024.234579
DO - 10.1016/j.jpowsour.2024.234579
M3 - Article
AN - SCOPUS:85190842594
SN - 0378-7753
VL - 606
JO - Journal of Power Sources
JF - Journal of Power Sources
M1 - 234579
ER -